Fundraising Fox
Pep Therapy
Paris, FR · 5 known investors
Find your way into Pep Therapy
PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.
Investors · 5
Italian Angels for Growth✓ confirmed by Pep TherapyMilan
How we know: the company's own site · Not right? Tell us
Seventure Partners✓ confirmed by Pep TherapyParis
How we know: the company's own site · Not right? Tell us
CAP HORN VCreportedParis · $1.1M – $22M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Pep Therapy do?
- PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.
- Who are Pep Therapy's investors?
- Pep Therapy's investors include Italian Angels for Growth, Doorway, Seventure Partners, Biotech Investments S.R.O, CAP HORN VC.
- Where is Pep Therapy headquartered?
- Pep Therapy is headquartered in Paris, FR.